Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
WINDLAS
WINDLAS

Windlas Biotech Ltd.

NSE: WINDLAS
BSE: 543329
Sector: Healthcare
Industry: Pharmaceuticals
872.70-31.7 (-3.51%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

82.5 / 100

Value Score

54.7 / 100

Price Momentum Score

70.0 / 100

QVM Score

87.5 / 100

Key Metrics

Market Cap
1800.90
P/E (TTM)
27.10
P/B
3.10
P/S (TTM)
1.91
EV/EBITDA
14.84
CAPE (5Y)
33.38
ROE (TTM)
12.23
ROCE (TTM)
12.82
ROA (TTM)
7.97
Avg 3Y ROE
12.88
Earnings 3Y CAGR
14.07
Sales 3Y CAGR
20.54
Sales 5Y CAGR
16.15
Debt/Equity
0.06
Consensus TP
-
Strong Buy %
-
Promoter Holding
63.31
Pledged %
0.00

Share Price

Track Windlas Biotech Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

872.70-31.7 (-3.51%)
-7.13% in past 1 year
1 Week returns: -4.37 %
Low
859.5
High
915.7
1 Month returns: -18.75 %
Low
859.5
High
1,139.9
1 Year returns: -7.13 %
Low
697.4
High
1,181.9
3 Year CAGR: 38.33 %
Low
311.6
High
1,198.3
5 Year CAGR: 21.78 %
Low
203.3
High
1,198.3
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Windlas Biotech Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Consistently pays dividend

The company has not missed dividend payments once in the last 4 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative
Low dividend yield

The company has a low dividend yield of 0.72%

What is Dividend yield?

Neutral
Stock appears expensive but is at a discount to industry median P/E

PE TTM of 27.1 indicates that the stock is expensive on a standalone basis but discount to industry median P/E is decent at -11.06%

What is P/E Ratio?

Median: 30.47
Value 27.1
-0.82614.73
Company's earnings are of moderate quality

Earnings quality score of 67.6 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

67.6 / 100

No red flags found!
No significant red flags found in the stock.

Financial Snapshot

See detailed analysis

Multi-year trends for Windlas Biotech Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
01k1k513.1 CrMar 2023631.0 CrMar 2024759.9 CrMar 2025904.1 CrMar 2026
Profit After Tax FY
00k0k0k0k42.6 CrMar 202358.2 CrMar 202461.0 CrMar 202566.5 CrMar 2026
ROE FY
0%5%10%15%10.7%Mar 202313.7%Mar 202412.8%Mar 202512.2%Mar 2026
EBITDA FY
00k0k0k60.2 CrMar 202378.2 CrMar 202494.5 CrMar 2025104.7 CrMar 2026

Windlas Biotech Ltd. Shareholding Pattern

Quarterly breakdown of Windlas Biotech Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Sep 2014Sep 2015Sep 2016Sep 2017Sep 2018Sep 2019Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Total Promoter
0.00
100.00
88.00
88.00
88.00
78.00
59.95
59.95
59.95
59.95
59.95
60.75
62.38
62.82
62.82
62.82
62.82
62.51
62.51
62.51
62.34
62.34
61.99
61.99
61.90
63.31
63.31
Indian Promoter
0.00
100.00
88.00
88.00
88.00
78.00
59.95
59.95
59.95
59.95
59.95
60.75
62.38
62.82
62.82
62.82
62.82
62.51
62.51
62.51
62.34
62.34
61.99
61.99
61.90
63.31
63.31
Foreign Promoter
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
0.00
0.00
0.00
0.00
0.00
22.00
16.99
15.07
13.23
15.44
13.33
13.65
12.93
12.33
12.33
13.06
13.00
11.94
11.58
11.81
12.41
12.65
12.54
12.37
12.41
11.88
9.32
Mutual Funds / UTI
0.00
0.00
0.00
0.00
0.00
0.00
9.31
9.90
9.50
11.90
10.89
11.39
10.64
10.51
10.43
10.40
10.37
8.70
7.57
7.11
6.70
6.80
6.39
6.63
7.08
5.76
3.10
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.12
0.12
0.12
0.12
0.04
0.04
0.04
0.04
0.04
0.04
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
6.24
3.77
3.40
3.21
2.19
1.45
1.32
0.80
0.80
1.35
1.18
1.59
2.00
1.55
1.52
1.44
1.11
0.93
0.60
2.04
2.09
Other Institutions
0.00
0.00
0.00
0.00
0.00
22.00
1.32
1.28
0.21
0.21
0.21
0.77
0.93
0.98
1.05
1.27
1.45
1.65
2.01
3.15
4.19
4.42
5.05
4.81
4.72
4.08
4.14
Non-Institution
100.00
0.00
12.00
12.00
12.00
0.00
23.06
24.99
26.82
24.62
26.72
25.59
24.69
24.85
24.86
24.12
24.19
25.55
25.91
25.68
25.25
25.01
25.47
25.64
25.70
24.80
27.36
Bodies Corporate
0.00
0.00
0.00
0.00
12.00
0.00
-
1.35
1.56
1.62
1.98
1.47
1.07
1.17
1.07
0.82
1.08
1.59
1.78
1.86
1.82
1.89
1.60
1.39
1.28
1.35
2.09
Others (incl. Retail)
No. of shareholders
100.00
7
0.00
5
12.00
6
12.00
6
0.00
5
0.00
5
23.06
1,08,790
23.64
99,108
25.26
91,974
23.00
88,603
24.74
86,649
24.12
82,548
23.62
79,097
23.68
75,313
23.79
68,656
23.30
61,758
23.11
51,133
23.96
45,655
24.13
45,504
23.82
46,376
23.43
46,176
23.12
45,670
23.87
45,225
24.25
45,252
24.42
44,571
23.45
44,768
25.27
48,460

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence
#IndexWeightRank
1SHI: Biotech2.73%11 / 15

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Windlas Biotech Ltd. shares as reported to NSE and BSE.

NameDateTypePriceQty.Value
AJAY KUMAR AGGARWAL20 Feb 2025buy₹ 787.421.45 lac₹ 11.42 cr
SAMVITTI CAPITAL PRIVATE LIMITED ACTIVE ALPHA MULTICAP19 Feb 2025sell₹ 683.491.15 lac₹ 7.89 cr
GRAVITON RESEARCH CAPITAL LLP01 Mar 2024buy₹ 565.961.11 lac₹ 6.26 cr
GRAVITON RESEARCH CAPITAL LLP01 Mar 2024sell₹ 564.941.11 lac₹ 6.25 cr
GRAVITON RESEARCH CAPITAL LLP08 Feb 2024buy₹ 522.391.35 lac₹ 7.07 cr
GRAVITON RESEARCH CAPITAL LLP08 Feb 2024sell₹ 522.271.35 lac₹ 7.07 cr
GRAVITON RESEARCH CAPITAL LLP02 Jan 2024buy₹ 517.174.10 lac₹ 21.19 cr
GRAVITON RESEARCH CAPITAL LLP02 Jan 2024sell₹ 517.504.10 lac₹ 21.20 cr
JAINAM BROKING LIMITED02 Jan 2024buy₹ 511.501.50 lac₹ 7.67 cr
JAINAM BROKING LIMITED02 Jan 2024sell₹ 520.7096.13 k₹ 5.01 cr

Corporate Actions

History of Windlas Biotech Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Dividend₹ 6.30/share
    Record date: 16th Jul 2026Ex-date: 16th Jul 2026
    Announced on: 21st May 2026
  2. Others
    Ex-date: 24th Apr 2026Announced on: 17th Apr 2026
    On Market Tender offer.
  3. Dividend₹ 5.80/share
    Record date: 21st Jul 2025Ex-date: 21st Jul 2025
    Announced on: 22nd May 2025
  4. Dividend₹ 5.50/share
    Record date: 17th Sep 2024Ex-date: 17th Sep 2024
    Announced on: 20th May 2024
  5. Dividend₹ 4/share
    Record date: 5th Sep 2023Ex-date: 5th Sep 2023
    Announced on: 5th May 2023

Company Profile

Overview of Windlas Biotech Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufactu...
Incorporated on
19 Feb 2001
Last Annual
31 Mar 2026
Last Interim
30 Jun 2026
No. of Employees
1,385
IPO date
16 Aug 2021
Free Float
69,71,739
Phone no.
+911242821030
Address
705-706, Vatika Professional Point, Sector-66 Golf Course Extension Road, GURGAON, 122001, India

Frequently Asked Questions

What is the current share price of Windlas Biotech Ltd.?
The current share price of Windlas Biotech Ltd. is ₹ 872.70 as of 23 Oct 2026.
What is the market capitalisation of Windlas Biotech Ltd.?
The market capitalisation of Windlas Biotech Ltd. stands at ₹ 1,800.90 Cr.
What is the PE ratio of Windlas Biotech Ltd.?
The Price-to-Earnings (PE) ratio of Windlas Biotech Ltd. is 27.10 as of the latest trailing twelve months data.
What is the ROE and ROCE of Windlas Biotech Ltd.?
Windlas Biotech Ltd. has a Return on Equity (ROE) of 12.23% and a Return on Capital Employed (ROCE) of 12.82% as per the latest financial reports.
What is the 52-week high and low of Windlas Biotech Ltd.?
The 52-week high of Windlas Biotech Ltd. is - and the 52-week low is -.
What is the dividend yield of Windlas Biotech Ltd.?
The dividend yield of Windlas Biotech Ltd. is 0.72% based on the current market price.
What is the FII and DII holding in Windlas Biotech Ltd.?
Foreign Institutional Investors (FII) hold 2.04%, Domestic Institutional Investors (DII) hold 5.76% and retail/public investors hold 23.45% of Windlas Biotech Ltd. shares.
What sector does Windlas Biotech Ltd. belong to?
Windlas Biotech Ltd. operates in the Healthcare sector.
What is the beta of Windlas Biotech Ltd.?
The beta of Windlas Biotech Ltd. is 0.64, indicating its price volatility relative to the broader market. Over the past 1 year, Windlas Biotech Ltd. has delivered an absolute return of -4.42%.
What is the RSI of Windlas Biotech Ltd.?
The 14-day Relative Strength Index (RSI) of Windlas Biotech Ltd. is 28.82, placing it in the oversold zone. An RSI above 70 is considered overbought and below 30 is considered oversold.